Welcome to the statistical phenomenon in health care known as "regional variation." The guru-researcher of regional variation is John Wennberg, who has detailed these trends in fhe Dartmouth Atlas.
New regional health spending data were published in Health Affairs, which we health economists and policy wonks eagerly anticipate each bi-monthly issue. The September/October issue covers "Caring for the Vulnerable." The regional variation report is a web exclusive, which you can access through this link. This map from the New York Times illustrates the variability.Why are there regional variations in health spending across states in the U.S.? There are many factors that contribute: the proportion of Medicare enrollees (i.e., elderly) and the proportion of Medicaid (which is the source of Alaska being a big per capita health spender) are big contributors to spending differences.
Another factor to consider is Roemer's Law: this was one of my earliest lessons in health economics back in the day. The concept is known as "supply-induced demand." In 1961, Milton Roemer (a fellow alum of the University of Michigan School of Public Health, although we graduated several decades apart) wrote a seminal paper on the relationship between the supply of hospital beds in a community and spending. Roemer found that, if a bed was built in a community, it was used and paid for. This may seem like a tautology. But the way Professor Paul Feldstein, health economist extraordinaire, explained it to me:
"A built bed is a filled bed is a billed bed."
According to Roemer's research, if you add a second hospital to a one-hospital town, the new one fills and the existing hospital stays filled. Similarly, when new digital technologies are introduced into a local community (such as MRI, CT, and PET scanning equipment), use of these technologies grows but they do not replace existing modalities. This creates a never-ending cost-spiral which contributes to regional spending variations (regions that become the technology "haves" vs. the "have-nots").
I'm absolutely not arguing against the adoption and use of new medical technology--just the rational, appropriate use of it based on evidence. Medical innovation is one of America's few areas of global competitive advantage (along with entertainment and fast food, a topic for another post). We must continue to nurture innovation, but do so in the context of evidence-based medicine.
Health Populi's Hot Points: As we add new health resources to a community, we often duplicate capital resources and add costs into the system. Medical technology is generally additive, not replacing. Adopting and using technology based on what will work for a specific patient -- the principles of evidence-based medicine -- will help to address variations, which will impact costs and improve quality.
2 Comments:
Dear Ms. Sarasohn-Kahn,
I'm enjoying your blog. You're providing interesting information and asking good questions.
In my view, we've been investing in healthcare technology, but in a perverse way. Most of the healthcare technology buzz seems to center around the hospital bed: CPOE, EMR, RFID, etc. The focus seems to be in the wrong place.
Because the focus is still on the diagnostic image, the procedure or the drug administration, those activities will become more efficient and be performed more often.
But, is that truly innovation?
I view healthcare innovation as a steady reduction of the skill level necessary to achieve a desired result. Innovation moves the diagnosis/treatment from the specialist to the generalist to the extender to self-care.
Might the focus on creating capacity for discrete procedures overshadow the overarching goal of restoring patient autonomy? I can see opposing economic forces within healthcare innovation.
Thanks for the interesting post and for considering my musings.
Ben
By
MedManager, At
September 19, 2007 9:03 AM
I really like your continuum of innovation moving from "the diagnosis/treatment from the specialist to the generalist to the extender to self-care." This involves the consumer/patient in co-creating their health, which must be where our health system goes to make us each responsible for personal health. You are right to raise the question about opposing economic forces: incentives are different when you take a system-wide view versus a micro (segment-specific) view.
By
Jane Sarasohn-Kahn, At
September 19, 2007 10:51 AM
Post a Comment
<< Home